CASI PHARMACEUTICALS, INC. Intangible Assets, Net (Excluding Goodwill)
CASI PHARMACEUTICALS, INC. had Intangible Assets, Net (Excluding Goodwill) of $1.06 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2023-04-26
- 2022-12-31: Intangible Assets, Net (Excluding Goodwill) $1.06M.
- 2022-09-30: Intangible Assets, Net (Excluding Goodwill) $10.05M.
- 2022-06-30: Intangible Assets, Net (Excluding Goodwill) $10.95M.
- 2022-03-31: Intangible Assets, Net (Excluding Goodwill) $11.90M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2022-12-31 | $1.06M 20-F · filed 2023-04-26 | |
| 2022-09-30 | $10.05M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $10.95M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $11.90M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $12.20M 20-F · filed 2023-04-26 | |
| 2021-09-30 | $12.36M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $12.69M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $12.83M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $13.21M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $13.02M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $13.14M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $16.29M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $13.67M 10-K · filed 2021-03-30 | $16.89M 10-K · filed 2020-03-16 |
| 2019-09-30 | $17.27M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $18.19M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $18.35M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $18.79M 10-K · filed 2020-03-16 | $18.78M 10-K · filed 2019-03-29 |
| 2018-09-30 | $17.11M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $17.46M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $17.80M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 |